Post-Approval Regulatory Maintenance

Post-approval regulatory maintenance is the ongoing FDA work that keeps marketed products in good standing after NDA, BLA, or device clearance/approval. Labeling updates, supplements and variations, annual reports, commitment tracking, and safety-related submissions all sit here. Neglect shows up as missed deadlines, inconsistent labels across markets, or inspection findings on open commitments that nobody owned after the launch celebration ended.

Viltis supports post-approval RA teams that are stretched across SKUs, indications, and manufacturing changes. We help prioritize change classifications, prepare CBE or prior-approval supplements as appropriate, coordinate labeling with medical and safety, and keep correspondence files inspection-ready. For devices, maintenance can include 510(k) supplements, annual reports where required, and alignment of UDI and labeling changes with quality change control so the field and the file stay in sync.

The practical goal is continuity: product stays available while changes move through the right regulatory paths with clean documentation. We work inside your change-control and RIM systems so maintenance is part of operations, not a separate hero effort every quarter when a manufacturing site, supplier, or packaging change suddenly needs a filing before the next batch ships.

Post-approval work also fails when safety updates, CMC changes, and promotional claims move on different clocks. Shared calendars and clear classification rules keep those streams from colliding in the field or creating label versions that sales and medical cannot reconcile. Portfolio companies with many SKUs benefit from a maintenance dashboard that shows open supplements, labeling versions in force, and commitment due dates in one place. We help design that operating rhythm with your RA and quality owners.

Post-approval maintenance commonly covers

• Supplement and variation strategy for manufacturing and labeling changes
• Annual report and commitment tracking calendars
• Labeling governance across USPI, carton/container, and digital assets
• Safety-driven updates coordinated with pharmacovigilance
• Health authority query management and response packages
• Device post-market regulatory change assessments

Handoffs between global affiliates and U.S. regulatory owners

Approval is a milestone, not an exit. Viltis helps you keep post-approval obligations current so commercial supply and regulatory status stay aligned across the product’s commercial life. Steady maintenance is quieter than a crisis filing, and cheaper than a stockout caused by a missed supplement or an outdated label in the field.